INS and metabolic syndrome: The impaired MEF2 binding to PGC-1α may then also explain the observation that carriers of the Gly482Ser SNP exhibit a reduced insulin sensitivity [33,34] and a higher risk for metabolic syndrome and type 2 diabetes [35,33,30,36,37].